ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LSTA vs ASBP // ENTERPRISE SCALE & MARKET CAP

Lisata Therapeutics Inc. (NASDAQ) VS. Aspire-Lakewood Holdings Inc. (NASDAQ) • 15-METRIC TALLY: LSTA 1 — ASBP 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ASBP
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LSTA VS. ASBP) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LSTA ASBP SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — -1.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -65.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 1/9 +2.00 LSTA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.1 45.7 -6.60 ASBP /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $11.0M $11.4M -$354.6K ASBP /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LSTA REV ASBP REV LSTA GROSS % ASBP GROSS % LSTA FCF ASBP FCF
FY 2025 $170.0K $6.2K — -1.9% -$16.0M -$4.9M
FY 2024 $1.0M $3.4M — — -$19.4M -$265.2K
FY 2023 $72.0M $20.1M — — -$20.0M -$653.1K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LSTA // BETA —
ASBP // BETA —